# Journal of Nuclear Medicine

Source: https://onco.cc/journals/journal-of-nuclear-medicine/  
OnCo record `journal-of-nuclear-medicine` (Journal). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

The Journal of Nuclear Medicine is the SNMMI's journal and the core venue for PET tracers and radioligand therapy: PSMA and somatostatin imaging, lutetium and actinium dosimetry, and theranostics trials.

## Summary

The Journal of Nuclear Medicine appears monthly and publishes first-in-human tracer studies, PSMA PET diagnostic accuracy trials, radioligand-therapy dosimetry and outcomes (lutetium-177 PSMA and DOTATATE, actinium-225), and SNMMI procedure standards. Articles become free to read after a delay; the SNMMI annual meeting abstracts are published as a supplement.

## Fields

- Kind: Journal
- Last checked: 2026-09-09
- Also known as: JNM; J Nucl Med
- Publisher: Society of Nuclear Medicine and Molecular Imaging
- Scope: nuclear medicine
- Access: hybrid

## Sources

- SNMMI: https://www.snmmi.org

## Connected records

- collections: [SNMMI Annual Meeting](https://onco.cc/collections/src-snmmi/)
- technologies: [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/)
- people: [Clemens Kratochwil](https://onco.cc/people/clemens-kratochwil/), [Frederik Giesel](https://onco.cc/people/frederik-giesel/), [Jason S. Lewis](https://onco.cc/people/jason-lewis/), [Jeremie Calais](https://onco.cc/people/jeremie-calais/), [Uwe Haberkorn](https://onco.cc/people/uwe-haberkorn/)
- key papers: [68 Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer](https://onco.cc/key-papers/paper-kratochwil-j-nucl-med/), [Biodistribution and Dosimetry of 18 F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies](https://onco.cc/key-papers/paper-pandit-taskar-j-nucl-med/), [CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89 Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody](https://onco.cc/key-papers/paper-farwell-j-nucl-med/), [Efficacy and safety of high-specific-activity 131I-MIBG therapy in advanced pheochromocytoma or paraganglioma](https://onco.cc/key-papers/paper-pryma-high-specific-activity-i131-mibg-ppgl-jnm-2019/), [First Human Imaging Studies with the EXPLORER Total-Body PET Scanner](https://onco.cc/key-papers/paper-badawi-j-nucl-med/), [First Safety and Efficacy Data with the Radiohybrid 177 Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer](https://onco.cc/key-papers/paper-nct05413850-j-nucl-med-2024/)

---
JSON: https://onco.cc/api/v1/entities/journal-of-nuclear-medicine.json